用 125I 标记载脂蛋白 CⅢ (apoCⅢ)为配体,采用聚乙二醇沉淀分离法,建立了小鼠肝细胞膜 apoCⅢ 受体(结合位点)放射分析法,并对人及小鼠肝细胞膜 apoCⅢ结合位点的特性进行了研究.
A specific,sensitive and simple radioligand binding assay for apoCⅢ-binding sites of hepatic plasma membranes has been established by separation of B/F with PEG.Addition of increasing concentration of 125Ⅰ-labeled apoCⅢ to human hepatic plasma membranes revealed saturation binding to membranes with a Kd of 0.31μmol/L(3.1×10-7mol/L) and binding maximum of 1.74μg/mg of membrane protein.In displacement studies using unlabeled apoCⅢ and isolated lipoproteins HDL,LDL and VLDL,only apoCⅢ and VLDL effectively competed with 125Ⅰ-apoCⅢ for membrane binding sites. The binding of 125Ⅰ-apoC l to human liver plasma membranes was Ca2+-independent and was abolished when plasma membranes were treated with trypsin. The characteristics of apoC Ⅲ-binding sites of mouse liver plasma membranes was similar to that of human liver plasma membranes with an exception of binding maximum of 1.52μg/mg of membrane protein.
方定志,刘秉文.人及小鼠肝细胞膜载脂蛋白 CⅢ受体的研究[J].生物化学与生物物理进展,1993,20(3):199-203
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号